Mr Matthew Swift
Introduction
The evolution of the remote monitoring of cardiovascular implantable electronic devices (CIEDs) in the last 10 years has seen a paradigm shift in technology, from the original analogue phone remote monitors with their induction loop headers, to the radio frequency (RF) devices we often see in use today, which require little patient interaction and can be remotely scheduled by the device clinic. Furthermore, modern devices perform routine tests assessing device function automatically, such that patients only require in-hospital visits for re-programming. Within the next couple of years, with the advent of Bluetoot
